Peptide-Conjugated Silver Nanoparticles for the Colorimetric Detection of the Oncoprotein Mdm2 in Human Serum.
Maurice RetoutBryan GosselinAlice MattiuzziIndiana TernadIvan JabinGilles BruylantsPublished in: ChemPlusChem (2022)
The development of efficient, reliable, and easy-to-use biosensors allowing early cancer diagnosis is of paramount importance for patients. Herein, we report a biosensor based on silver nanoparticles functionalized by peptide aptamers for the detection of a cancer biomarker, i. e. the Mdm2 protein. Silver nanoparticles (AgNPs) were produced and stabilized with a thin PEGylated-calix[4]arene layer that allows (i) the steric stabilization of the AgNPs and (ii) the covalent conjugation of the peptide aptamers via the formation of an amide bond. These peptide-conjugated AgNPs were then used to detect Mdm2 via a dual trapping strategy that was previously reported with gold nanoparticles (AuNPs). Our results showed that replacing AuNPs by AgNPs improves the detection limit by nearly one order of magnitude, down to 5 nM, while the high selectivity of the system and the stability of the particles provided by the calixarene coating allow the detection of Mdm2 in human serum.
Keyphrases
- silver nanoparticles
- gold nanoparticles
- label free
- loop mediated isothermal amplification
- real time pcr
- papillary thyroid
- photodynamic therapy
- end stage renal disease
- ejection fraction
- squamous cell carcinoma
- squamous cell
- chronic kidney disease
- newly diagnosed
- sensitive detection
- young adults
- high resolution
- prognostic factors
- peritoneal dialysis
- childhood cancer
- fluorescent probe
- molecularly imprinted
- structural basis
- solid phase extraction